Helena M.
- Country
- Sweden
- Department
- Pediatric Oncology
Research Overview
- Evaluation of Triptorelin for Ovarian Reserve Preservation in Young Females Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas
- Evaluation of Hyperfractionated-Accelerated Radiotherapy and High-Dose Thiotepa Therapy in High-Risk Medulloblastoma Patients Aged Over 3 Years
- Phase 3 Randomized Trial of Tovorafenib Monotherapy vs. Standard Chemotherapy in Pediatric Low-Grade Glioma with RAF Alteration
Data & Insights
Has run more than one trial at 91 of 158 partner sites.
Specializations
Oncology Research
This investigator specializes in breast cancer treatment and its intersection with reproductive health, particularly studying the effects of chemotherapy on ovarian reserve. Their work includes assessment of Anti-Müllerian Hormone levels in cancer patients.
- Breast Cancer
- Acute Leukemia
- Lymphomas
- Sarcomas
Neuro-Oncology
The investigator focuses on advanced treatment approaches for medulloblastoma, particularly in high-risk cases. Their research encompasses various histological subtypes and molecular classifications including sonic hedgehog (SHH) subgroup tumors.
- High-Risk Medulloblastoma
- Standard-Risk Medulloblastoma
- Pediatric Brain Tumors
Pediatric Oncology
Their expertise extends to pediatric low-grade gliomas, with particular attention to tumors with RAF alterations. The investigator evaluates novel therapeutic approaches including targeted therapies against conventional treatments.
- Low-Grade Gliomas
- RAF-Altered Tumors
- First-Line Systemic Therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.